A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Ovarian Neoplasms|Breast Neoplasms
Interventions: DRUG: Niraparib
Sponsor: GlaxoSmithKline